These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 6680095

  • 1. Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin.
    Cruce DD, Wachsmuth IK, Feeley JC.
    Diagn Immunol; 1983; 1(2):87-9. PubMed ID: 6680095
    [Abstract] [Full Text] [Related]

  • 2. Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.
    Young CR, Levine MM, Craig JP, Robins-Browne R.
    Infect Immun; 1980 Feb; 27(2):492-6. PubMed ID: 7189746
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK, Siber GR.
    Dev Biol Stand; 1996 Feb; 86():207-15. PubMed ID: 8785950
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The adjuvant effect of pertussis endotoxin protein in modulating the immune response to cholera toxoid in mice.
    Sultzer BM, Craig JP, Castagna R.
    Dev Biol Stand; 1985 Feb; 61():225-32. PubMed ID: 2872108
    [Abstract] [Full Text] [Related]

  • 7. Further studies on the cholera toxin and antitoxin.
    Ungar J, Stanić M, Varallyay SJ, Chariatte N.
    Prog Immunobiol Stand; 1970 Feb; 4():583-9. PubMed ID: 4099025
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholera toxoid boosts serum Escherichia coli antitoxin in humans.
    Nalin DR, al-Mahmud A, Curlin G, Ahmed A, Peterson J.
    Infect Immun; 1974 Oct; 10(4):747-9. PubMed ID: 4609909
    [Abstract] [Full Text] [Related]

  • 11. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
    Snyder JD, Allegra DT, Levine MM, Craig JP, Feeley JC, DeWitt WE, Blake PA.
    J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
    [Abstract] [Full Text] [Related]

  • 12. Protection against experimental cholera by oral or parenteral immunization.
    Peterson JW.
    Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cholera toxin and toxoid.
    Ungar J, Stanić M, Chariatte N, Varallyay SJ.
    Prog Immunobiol Stand; 1971 Nov; 5():348-9. PubMed ID: 4660540
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
    Clements ML, Levine MM, Young CR, Black RE, Lim YL, Robins-Browne RM, Craig JP.
    J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.